|
|
Increasing knowledge of cell function in dermal wound healing is allowing development of advanced bioactive woundcare products that will take an increasing market share in the future. These products will incorporate technologies such as growth factors and cytokines, tissue engineered skin substitutes / replacements, interactive treatments that modify the wound environment and pharmacologic agents modulating cell function. Identification of novel therapeutic genes is underway. Their delivery to wounds has been achieved in animals and human wound gene therapy is on the horizon. These exciting developments have required established wound dressing manufacturers to make a paradigm shift and aquire the expertise required to apply the output of recent biotechnology research. Biotech and pharma companies with in-house biotechnology research programmes have either to aquire wound healing skills or license out their developed technology for third party development and clinical trials. Additionally universities are seeking commercial outlets for their research. Evaluation and application of these crossover technologies requires expertise in the cell biology of wound healing and clinical science. Understanding of the practical issues involved in the design and interpretation of clinical and laboratory studies enhances product development and communication of the underllying scientific principles to a wide audience in the healthcare field. The services offered by Keith Moore provide the appropriate skills to enhance your product development and marketing programme. |
||||||||||||
